+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biomaterials Market - Global Forecast 2026-2032- Product Image
Biomaterials Market - Global Forecast 2026-2032- Product Image
Sale

Biomaterials Market - Global Forecast 2026-2032

  • Report

  • 191 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 6083096
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biomaterials Market is projected to reach USD 63.02 Billion in 2026. It is expected to continue growing at a CAGR of 12.92%, reaching USD 131.30 Billion by 2032.

The biomaterials market is increasingly central to modern healthcare, spanning biocompatible metals, ceramics, polymers, hydrogels, composites, and bioresorbable materials used in implants, wound care, drug delivery, tissue engineering, dental products, and advanced surgical devices.

Growth is also shaped by aging populations, higher surgical volumes, stronger reimbursement scrutiny, and stricter biocompatibility expectations under frameworks such as ISO 10993, U.S. FDA guidance, and the European Union Medical Device Regulation. As a result, industry leaders are prioritizing materials that demonstrate safety, durability, manufacturability, sterilization compatibility, and measurable patient outcomes.

Transformative Shifts in the Biomaterials Landscape

The biomaterials landscape is shifting from inert, replacement-focused materials toward functional platforms that actively interact with biological systems. Orthopedic and dental applications still rely heavily on titanium alloys, stainless steel, cobalt-chromium, alumina, and zirconia, but the fastest innovation is occurring in bioactive ceramics, degradable polymers, antimicrobial coatings, hydrogels, extracellular matrix materials, and engineered tissue scaffolds.

Regulatory expectations are transforming product development. The EU MDR has raised clinical evidence requirements, while the FDA continues to emphasize risk-based biocompatibility assessment, chemical characterization, and device-specific performance testing. This is pushing manufacturers to invest earlier in toxicology, extractables and leachables, sterility assurance, usability, and long-term post-market surveillance.

Supply chain resilience is another defining shift. Medical-grade polymers, specialty ceramics, rare metals, collagen sources, and validated contract manufacturing capacity are now strategic assets. Companies that can qualify alternative suppliers, document traceability, maintain consistent material specifications, and reduce single-source exposure are better positioned to protect quality, support approvals, and sustain clinical supply.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a practical accelerator across biomaterials discovery, characterization, and manufacturing. Machine learning models can screen polymer chemistries, predict mechanical properties, evaluate degradation profiles, and identify structure-property relationships faster than traditional trial-and-error experimentation.

AI is especially valuable where biomaterials require simultaneous optimization across competing factors, including tensile strength, elasticity, porosity, bioactivity, cytocompatibility, hemocompatibility, sterilization tolerance, and cost. Digital image analysis is improving histology interpretation, surface morphology evaluation, contamination detection, and defect identification in additive manufacturing and coating processes.

The cumulative impact is a shorter development cycle, stronger design controls, and more evidence-rich regulatory submissions. However, AI adoption must be governed by validated datasets, explainable models, cybersecurity controls, audit trails, and documented change management, particularly when algorithmic outputs influence device design, process validation, or quality release decisions.

Key Regional Insights for Biomaterials

Asia-Pacific is emerging as a high-growth biomaterials hub, supported by large patient populations, expanding medical device manufacturing, and policy support for domestic innovation in China, India, Japan, South Korea, and Australia. Demand is strongest in orthopedic implants, dental biomaterials, cardiovascular devices, wound care, ophthalmology, and regenerative medicine, with aging demographics in Japan and South Korea and rising chronic disease burdens in China and India reinforcing long-term clinical need.

North America remains a leading commercialization region due to established hospital infrastructure, high procedure volumes, strong biomedical research funding, FDA-recognized testing pathways, and deep university-clinician-manufacturer collaboration. The United States is particularly influential in advanced polymers, tissue scaffolds, drug-device combinations, resorbable materials, and 3D-printed implant platforms, while Canada adds strength in regenerative medicine, clinical research networks, and publicly supported health innovation.

Europe is defined by premium clinical standards, sustainability priorities, and rigorous evidence requirements under EU MDR. Germany, France, Italy, Spain, and the United Kingdom support strong adoption in dental, orthopedic, wound care, cardiovascular, and tissue engineering applications. Latin America is led by Brazil and Mexico, where rising private healthcare access, trauma care needs, dental procedures, and medical tourism support demand for cost-effective and clinically proven biomaterials. The Middle East is investing in specialty care, advanced hospitals, and surgical capacity, especially across GCC markets, while Africa presents long-term potential tied to healthcare access expansion, orthopedic trauma care, maternal health systems, and affordable wound management solutions.

Key Group Insights Across Global Biomaterials Markets

ASEAN markets are gaining relevance as medical tourism, hospital investment, and local device assembly expand across Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines. The region is well positioned for dental products, wound dressings, surgical consumables, and cost-competitive polymer-based devices, although regulatory harmonization, product registration efficiency, and clinical validation remain important differentiators.

The GCC is prioritizing advanced healthcare capacity, specialty surgery, domestic life sciences investment, and medical technology localization, creating opportunities for premium orthopedic, dental, cardiovascular, and wound-care biomaterials. The European Union remains a benchmark market because EU MDR compliance often strengthens credibility in other jurisdictions, making clinical evidence, post-market surveillance, traceability, and risk management essential competitive assets.

BRICS countries represent large-volume clinical demand and manufacturing scale, led by China, India, and Brazil, with Russia and South Africa contributing needs in trauma care, orthopedics, and hospital modernization. G7 markets lead in high-value innovation, reimbursement sophistication, biocompatibility science, and clinical adoption of next-generation biomaterials. NATO-linked procurement priorities can also influence trauma care, surgical readiness, infection control, burn treatment, and resilient medical supply chains, particularly for materials used in emergency and defense-related healthcare settings.

Key Country Insights for Biomaterials

The United States leads in biomaterials innovation through strong medtech ecosystems, federally funded biomedical research, FDA engagement, and commercialization in orthopedic, cardiovascular, wound care, dental, ophthalmic, and drug delivery applications. Canada benefits from regenerative medicine research, biomaterials science, and hospital-based innovation, while Mexico is strengthening its role in medical device manufacturing, nearshoring, and cross-border supply chain integration.

Brazil is the most influential Latin American biomaterials market, supported by orthopedic, dental, trauma, and hospital demand, while Mexico continues to benefit from private healthcare expansion and device production capabilities. The United Kingdom has deep strengths in university-led materials science, translational research, and advanced therapy development. Germany remains a European anchor for precision engineering, implantable devices, and dental biomaterials, while France supports strong clinical research, healthcare infrastructure, and implantable device expertise. Italy and Spain contribute established dental, orthopedic, and biomedical manufacturing capabilities, while Russia maintains demand in trauma, orthopedics, and domestic substitution strategies.

China is scaling domestic biomaterials production and high-volume clinical adoption, supported by hospital expansion, orthopedic demand, and policy emphasis on medical technology self-sufficiency. India is driven by affordability, expanding hospitals, dental care growth, and a large chronic disease burden, including diabetes-related wound care needs. Japan is a leader in high-quality ceramics, aging-related implant demand, and regenerative medicine regulation. Australia supports advanced clinical research, trauma care, and specialty adoption, while South Korea combines electronics, precision manufacturing, dental expertise, aesthetic procedures, and strong hospital technology adoption to strengthen its biomaterials position.

Actionable Recommendations for Biomaterials Leaders

Industry leaders should prioritize biomaterial platforms that address clear clinical burdens, including musculoskeletal disease, diabetes-related wounds, cardiovascular disease, dental restoration, ophthalmic disorders, and age-related tissue degeneration. Portfolio decisions should be anchored in measurable outcomes such as reduced infection, faster healing, improved osseointegration, longer implant life, reduced inflammation, and fewer revision procedures.

Companies should integrate biocompatibility, sterilization, manufacturability, and regulatory strategy from the earliest design stage. Building ISO 10993-aligned testing plans, chemical characterization workflows, risk management files, usability evidence, and post-market evidence systems can reduce approval risk and strengthen payer and clinician confidence.

Leaders should also invest in AI-enabled materials discovery, additive manufacturing validation, supplier diversification, lifecycle sustainability, and robust quality systems. Strategic partnerships with hospitals, universities, contract research organizations, testing laboratories, and specialty manufacturers can accelerate clinical validation, improve product performance, and support faster market access.

Research Methodology

This executive summary is developed using a structured secondary research approach aligned with market intelligence best practices. Inputs include public health datasets, regulatory guidance, peer-reviewed literature, medical device standards, clinical adoption trends, manufacturing indicators, and macroeconomic factors relevant to biomaterials demand.

Key sources considered include the World Health Organization, International Diabetes Federation, United Nations population data, U.S. FDA guidance, European Commission medical device regulations, ISO standards, OECD health indicators, national healthcare statistics, and published scientific research on biomaterials performance, biocompatibility, degradation behavior, and clinical use.

The analysis triangulates clinical need, regulatory direction, material innovation, manufacturing capacity, supply chain resilience, and regional healthcare investment. Qualitative insights are validated against observable market drivers and documented healthcare indicators rather than unsupported projections, supporting an evidence-based view of biomaterials opportunities.

Conclusion

Biomaterials are moving from passive structural components to intelligent, bioactive, and application-specific platforms that support better patient outcomes. Demand is reinforced by aging demographics, chronic disease prevalence, surgical innovation, trauma care needs, and the requirement for safer, longer-lasting medical technologies.

The most competitive organizations will combine scientific rigor with scalable manufacturing, regulatory readiness, and clinical evidence generation. AI, additive manufacturing, surface engineering, antimicrobial technologies, bioresorbable materials, and regenerative medicine will continue to reshape how biomaterials are discovered, tested, and commercialized.

Regional growth patterns will differ by healthcare infrastructure, reimbursement maturity, regulatory readiness, and manufacturing capacity, but the global direction is clear: validated, high-performance biomaterials will remain essential to the future of medical devices, implants, wound care, drug delivery, and tissue repair.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Biomaterials Market, by Type
7.1. Introduction
7.2. Ceramics
7.2.1. Alumina
7.2.2. Bioglass
7.2.3. Hydroxyapatite
7.2.4. Zirconia
7.3. Metallic
7.4. Synthetic Polymers
7.4.1. Polycaprolactone (PCL)
7.4.2. Polyglycolic acid (PGA)
7.4.3. Polylactic acid (PLA)
7.4.4. Polylactic-co-glycolic acid (PLGA)
7.4.5. Polyethylene (PE)
7.4.6. Polypropylene (PP)
7.4.7. Polyurethane (PU)
7.4.8. Polyvinyl alcohol (PVA)
8. Biomaterials Market, by Product Form
8.1. Introduction
8.2. Powders & Granules
8.3. Fibers & Meshes
8.4. Films
8.5. Foams
8.6. Coatings
9. Biomaterials Market, by Application
9.1. Introduction
9.2. Cardiovascular
9.2.1. Guidewires
9.2.2. Implantable Cardiac Defibrillators
9.2.3. Pacemakers
9.2.4. Sensors
9.2.5. Stents
9.2.6. Vascular Grafts
9.3. Dental
9.3.1. Bone Grafts & Substitutes
9.3.2. Dental Implants
9.3.3. Dental Membranes
9.3.4. Tissue Regeneration Materials
9.4. Ophthalmology
9.5. Orthopedic
9.5.1. Bioresorbable Tissue Fixation Products
9.5.2. Joint Replacement biomaterials
9.5.3. Orthobiologics
9.5.4. Spine Biomaterials
9.5.5. Viscosupplementation
9.6. Urinary
9.7. Wound Healing
9.7.1. Adhesion Barrier
9.7.2. Fracture Healing Device
9.7.3. Internal Tissue Sealant
9.7.4. Skin Substitutes
9.7.5. Surgical Hemostats
10. Biomaterials Market, by End User
10.1. Introduction
10.2. Biotechnology Companies
10.3. Hospitals
10.4. Research Laboratories
10.5. Specialty Clinics
11. Biomaterials Market, by Region
11.1. Asia-Pacific
11.2. North America
11.3. Latin America
11.4. Europe
11.5. Middle East
11.6. Africa
12. Biomaterials Market, by Group
12.1. ASEAN
12.2. GCC
12.3. European Union
12.4. BRICS
12.5. G7
12.6. NATO
13. Biomaterials Market, by Country
13.1. United States
13.2. Germany
13.3. China
13.4. United Kingdom
13.5. India
13.6. Japan
13.7. Russia
13.8. Brazil
13.9. Canada
13.10. Italy
13.11. Mexico
13.12. France
13.13. Spain
13.14. Australia
13.15. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. FPNV Positioning Matrix, 2025
14.3. Market Concentration Analysis, 2025
14.3.1. Concentration Ratio (CR)
14.3.2. Herfindahl Hirschman Index (HHI)
14.4. Recent Developments & Impact Analysis, 2025
14.5. Product Portfolio Analysis, 2025
14.6. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Aroa Biosurgery Limited
15.2. BASF SE
15.3. Berkeley Advanced Biomaterials Inc.
15.4. Bezwada Biomedical, LLC
15.5. Carpenter Technology Corporation
15.6. Celanese Corporation
15.7. CoorsTek, Inc.
15.8. Corbion N.V.
15.9. Covestro AG
15.10. Dentsply Sirona Inc.
15.11. DSM-Firmenich AG
15.12. Evonik Industries AG
15.13. Exactech, Inc.
15.14. Heraeus Holding GmbH
15.15. Integra LifeSciences Corporation
15.16. Invibio Limited
15.17. Modern Meadow, Inc.
15.18. MycoWorks, Inc.
15.19. Noble Biomaterials, Inc.
15.20. Stryker Corporation
15.21. TissueForm, Inc.
15.22. W. L. Gore & Associates, Inc.
List of Figures
FIGURE 1. GLOBAL BIOMATERIALS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL BIOMATERIALS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL BIOMATERIALS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL BIOMATERIALS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL BIOMATERIALS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL BIOMATERIALS MARKET SIZE, BY TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL BIOMATERIALS MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2025 VS 2032 (%)
FIGURE 9. GLOBAL BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BIOMATERIALS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL BIOMATERIALS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BIOMATERIALS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL BIOMATERIALS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL BIOMATERIALS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL BIOMATERIALS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL BIOMATERIALS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 17. GLOBAL BIOMATERIALS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL BIOMATERIALS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL BIOMATERIALS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL BIOMATERIALS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 21. GLOBAL BIOMATERIALS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL BIOMATERIALS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL BIOMATERIALS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL BIOMATERIALS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CERAMICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CERAMICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CERAMICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL ALUMINA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL ALUMINA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL ALUMINA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL BIOGLASS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL BIOGLASS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL BIOGLASS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL HYDROXYAPATITE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL HYDROXYAPATITE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL HYDROXYAPATITE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL ZIRCONIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL ZIRCONIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL ZIRCONIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL METALLIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL METALLIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL METALLIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL SYNTHETIC POLYMERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL SYNTHETIC POLYMERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL SYNTHETIC POLYMERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL POLYCAPROLACTONE (PCL) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL POLYCAPROLACTONE (PCL) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL POLYCAPROLACTONE (PCL) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL POLYGLYCOLIC ACID (PGA) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL POLYGLYCOLIC ACID (PGA) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL POLYGLYCOLIC ACID (PGA) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL POLYLACTIC ACID (PLA) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL POLYLACTIC ACID (PLA) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL POLYLACTIC ACID (PLA) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL POLYLACTIC-CO-GLYCOLIC ACID (PLGA) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL POLYLACTIC-CO-GLYCOLIC ACID (PLGA) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL POLYLACTIC-CO-GLYCOLIC ACID (PLGA) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL POLYETHYLENE (PE) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL POLYETHYLENE (PE) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL POLYETHYLENE (PE) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL POLYPROPYLENE (PP) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL POLYPROPYLENE (PP) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL POLYPROPYLENE (PP) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL POLYURETHANE (PU) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL POLYURETHANE (PU) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL POLYURETHANE (PU) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL POLYVINYL ALCOHOL (PVA) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL POLYVINYL ALCOHOL (PVA) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL POLYVINYL ALCOHOL (PVA) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL POWDERS & GRANULES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL POWDERS & GRANULES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL POWDERS & GRANULES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL FIBERS & MESHES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL FIBERS & MESHES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL FIBERS & MESHES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL FILMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL FILMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL FILMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL FOAMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL FOAMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL FOAMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL COATINGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL COATINGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL COATINGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL BIOMATERIALS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL CARDIOVASCULAR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL CARDIOVASCULAR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL CARDIOVASCULAR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL GUIDEWIRES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL GUIDEWIRES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL GUIDEWIRES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL IMPLANTABLE CARDIAC DEFIBRILLATORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL IMPLANTABLE CARDIAC DEFIBRILLATORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL IMPLANTABLE CARDIAC DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL PACEMAKERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL PACEMAKERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL PACEMAKERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL SENSORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL SENSORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL SENSORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL STENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL VASCULAR GRAFTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL VASCULAR GRAFTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL VASCULAR GRAFTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL DENTAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL DENTAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL DENTAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL BONE GRAFTS & SUBSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL DENTAL IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL DENTAL IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL DENTAL IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL DENTAL MEMBRANES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL DENTAL MEMBRANES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL DENTAL MEMBRANES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL TISSUE REGENERATION MATERIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL TISSUE REGENERATION MATERIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL TISSUE REGENERATION MATERIALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL ORTHOPEDIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL ORTHOPEDIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL ORTHOPEDIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL BIORESORBABLE TISSUE FIXATION PRODUCTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL BIORESORBABLE TISSUE FIXATION PRODUCTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL BIORESORBABLE TISSUE FIXATION PRODUCTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL JOINT REPLACEMENT BIOMATERIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL JOINT REPLACEMENT BIOMATERIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL JOINT REPLACEMENT BIOMATERIALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL SPINE BIOMATERIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL SPINE BIOMATERIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL SPINE BIOMATERIALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL URINARY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL URINARY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL URINARY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL WOUND HEALING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL WOUND HEALING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL WOUND HEALING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL ADHESION BARRIER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL ADHESION BARRIER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL ADHESION BARRIER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL FRACTURE HEALING DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL FRACTURE HEALING DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL FRACTURE HEALING DEVICE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL INTERNAL TISSUE SEALANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL INTERNAL TISSUE SEALANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL INTERNAL TISSUE SEALANT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL SKIN SUBSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL SKIN SUBSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL SURGICAL HEMOSTATS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL SURGICAL HEMOSTATS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL SURGICAL HEMOSTATS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL BIOMATERIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 148. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 149. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 150. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 151. GLOBAL RESEARCH LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 152. GLOBAL RESEARCH LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 153. GLOBAL RESEARCH LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 154. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 155. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 156. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 157. GLOBAL BIOMATERIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY CERAMICS, 2017-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2017-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY DENTAL, 2017-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2017-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 169. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 170. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 171. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY CERAMICS, 2017-2032 (USD MILLION)
TABLE 172. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2017-2032 (USD MILLION)
TABLE 173. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 174. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 175. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 176. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY DENTAL, 2017-2032 (USD MILLION)
TABLE 177. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 178. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2017-2032 (USD MILLION)
TABLE 179. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 180. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 181. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 182. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY CERAMICS, 2017-2032 (USD MILLION)
TABLE 183. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2017-2032 (USD MILLION)
TABLE 184. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 185. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 186. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 187. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY DENTAL, 2017-2032 (USD MILLION)
TABLE 188. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 189. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2017-2032 (USD MILLION)
TABLE 190. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 191. EUROPE BIOMATERIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 192. EUROPE BIOMATERIALS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 193. EUROPE BIOMATERIALS MARKET SIZE, BY CERAMICS, 2017-2032 (USD MILLION)
TABLE 194. EUROPE BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2017-2032 (USD MILLION)
TABLE 195. EUROPE BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 196. EUROPE BIOMATERIALS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 197. EUROPE BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 198. EUROPE BIOMATERIALS MARKET SIZE, BY DENTAL, 2017-2032 (USD MILLION)
TABLE 199. EUROPE BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 200. EUROPE BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2017-2032 (USD MILLION)
TABLE 201. EUROPE BIOMATERIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 202. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 203. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 204. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY CERAMICS, 2017-2032 (USD MILLION)
TABLE 205. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2017-2032 (USD MILLION)
TABLE 206. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 207. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 208. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 209. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY DENTAL, 2017-2032 (USD MILLION)
TABLE 210. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 211. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2017-2032 (USD MILLION)
TABLE 212. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 213. AFRICA BIOMATERIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 214. AFRICA BIOMATERIALS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 215. AFRICA BIOMATERIALS MARKET SIZE, BY CERAMICS, 2017-2032 (USD MILLION)
TABLE 216. AFRICA BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2017-2032 (USD MILLION)
TABLE 217. AFRICA BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 218. AFRICA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 219. AFRICA BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 220. AFRICA BIOMATERIALS MARKET SIZE, BY DENTAL, 2017-2032 (USD MILLION)
TABLE 221. AFRICA BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 222. AFRICA BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2017-2032 (USD MILLION)
TABLE 223. AFRICA BIOMATERIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 224. GLOBAL BIOMATERIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 225. ASEAN BIOMATERIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 226. ASEAN BIOMATERIALS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 227. ASEAN BIOMATERIALS MARKET SIZE, BY CERAMICS, 2017-2032 (USD MILLION)
TABLE 228. ASEAN BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2017-2032 (USD MILLION)
TABLE 229. ASEAN BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 230. ASEAN BIOMATERIALS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 231. ASEAN BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 232. ASEAN BIOMATERIALS MARKET SIZE, BY DENTAL, 2017-2032 (USD MILLION)
TABLE 233. ASEAN BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 234. ASEAN BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2017-2032 (USD MILLION)
TABLE 235. ASEAN BIOMATERIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 236. GCC BIOMATERIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 237. GCC BIOMATERIALS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 238. GCC BIOMATERIALS MARKET SIZE, BY CERAMICS, 2017-2032 (USD MILLION)
TABLE 239. GCC BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2017-2032 (USD MILLION)
TABLE 240. GCC BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 241. GCC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 242. GCC BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 243. GCC BIOMATERIALS MARKET SIZE, BY DENTAL, 2017-2032 (USD MILLION)
TABLE 244. GCC BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 245. GCC BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2017-2032 (USD MILLION)
TABLE 246. GCC BIOMATERIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 249. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY CERAMICS, 2017-2032 (USD MILLION)
TABLE 250. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2017-2032 (USD MILLION)
TABLE 251. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 252. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 253. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 254. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY DENTAL, 2017-2032 (USD MILLION)
TABLE 255. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 256. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2017-2032 (USD MILLION)
TABLE 257. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 258. BRICS BIOMATERIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 259. BRICS BIOMATERIALS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 260. BRICS BIOMATERIALS MARKET SIZE, BY CERAMICS, 2017-2032 (USD MILLION)
TABLE 261. BRICS BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2017-2032 (USD MILLION)
TABLE 262. BRICS BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 263. BRICS BIOMATERIALS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 264. BRICS BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 265. BRICS BIOMATERIALS MARKET SIZE, BY DENTAL, 2017-2032 (USD MILLION)
TABLE 266. BRICS BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 267. BRICS BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2017-2032 (USD MILLION)
TABLE 268. BRICS BIOMATERIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 269. G7 BIOMATERIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 270. G7 BIOMATERIALS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 271. G7 BIOMATERIALS MARKET SIZE, BY CERAMICS, 2017-2032 (USD MILLION)
TABLE 272. G7 BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2017-2032 (USD MILLION)
TABLE 273. G7 BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 274. G7 BIOMATERIALS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 275. G7 BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 276. G7 BIOMATERIALS MARKET SIZE, BY DENTAL, 2017-2032 (USD MILLION)
TABLE 277. G7 BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 278. G7 BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2017-2032 (USD MILLION)
TABLE 279. G7 BIOMATERIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 280. NATO BIOMATERIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 281. NATO BIOMATERIALS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 282. NATO BIOMATERIALS MARKET SIZE, BY CERAMICS, 2017-2032 (USD MILLION)
TABLE 283. NATO BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2017-2032 (USD MILLION)
TABLE 284. NATO BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 285. NATO BIOMATERIALS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 286. NATO BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 287. NATO BIOMATERIALS MARKET SIZE, BY DENTAL, 2017-2032 (USD MILLION)
TABLE 288. NATO BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 289. NATO BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2017-2032 (USD MILLION)
TABLE 290. NATO BIOMATERIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 291. GLOBAL BIOMATERIALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 292. UNITED STATES BIOMATERIALS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 293. UNITED STATES BIOMATERIALS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 294. UNITED STATES BIOMATERIALS MARKET SIZE, BY CERAMICS, 2017-2032 (USD MILLION)
TABLE 295. UNITED STATES BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2017-2032 (USD MILLION)
TABLE 296. UNITED STATES BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 297. UNITED STATES BIOMATERIALS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 298. UNITED STATES BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 299. UNITED STATES BIOMATERIALS MARKET SIZE, BY DENTAL, 2017-2032 (USD MILLION)
TABLE 300. UNITED STATES BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 301. UNITED STATES BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2017-2032 (USD MILLION)
TABLE 302. UNITED STATES BIOMATERIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 303. GERMANY BIOMATERIALS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 304. GERMANY BIOMATERIALS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 305. GERMANY BIOMATERIALS MARKET SIZE, BY CERAMICS, 2017-2032 (USD MILLION)
TABLE 306. GERMANY BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2017-2032 (USD MILLION)
TABLE 307. GERMANY BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 308. GERMANY BIOMATERIALS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 309. GERMANY BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 310. GERMANY BIOMATERIALS MARKET SIZE, BY DENTAL, 2017-2032 (USD MILLION)
TABLE 311. GERMANY BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 312. GERMANY BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2017-2032 (USD MILLION)
TABLE 313. GERMANY BIOMATERIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 314. CHINA BIOMATERIALS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 315. CHINA BIOMATERIALS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 316. CHINA BIOMATERIALS MARKET SIZE, BY CERAMICS, 2017-2032 (USD MILLION)
TABLE 317. CHINA BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2017-2032 (USD MILLION)
TABLE 318. CHINA BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 319. CHINA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 320. CHINA BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 321. CHINA BIOMATERIALS MARKET SIZE, BY DENTAL, 2017-2032 (USD MILLION)
TABLE 322. CHINA BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 323. CHINA BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2017-2032 (USD MILLION)
TABLE 324. CHINA BIOMATERIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 325. UNITED KINGDOM BIOMATERIALS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 326. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 327. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY CERAMICS, 2017-2032 (USD MILLION)
TABLE 328. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2017-2032 (USD MILLION)
TABLE 329. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 330. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 331. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 332. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY DENTAL, 2017-2032 (USD MILLION)
TABLE 333. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 334. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2017-2032 (USD MILLION)
TABLE 335. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 336. INDIA BIOMATERIALS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 337. INDIA BIOMATERIALS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 338. INDIA BIOMATERIALS MARKET SIZE, BY CERAMICS, 2017-2032 (USD MILLION)
TABLE 339. INDIA BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2017-2032 (USD MILLION)
TABLE 340. INDIA BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 341. INDIA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 342. INDIA BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 343. INDIA BIOMATERIALS MARKET SIZE, BY DENTAL, 2017-2032 (USD MILLION)
TABLE 344. INDIA BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 345. INDIA BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2017-2032 (USD MILLION)
TABLE 346. INDIA BIOMATERIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 347. JAPAN BIOMATERIALS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 348. JAPAN BIOMATERIALS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 349. JAPAN BIOMATERIALS MARKET SIZE, BY CERAMICS, 2017-2032 (USD MILLION)
TABLE 350. JAPAN BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2017-2032 (USD MILLION)
TABLE 351. JAPAN BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 352. JAPAN BIOMATERIALS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 353. JAPAN BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 354. JAPAN BIOMATERIALS MARKET SIZE, BY DENTAL, 2017-2032 (USD MILLION)
TABLE 355. JAPAN BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 356. JAPAN BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2017-2032 (USD MILLION)
TABLE 357. JAPAN BIOMATERIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 358. RUSSIA BIOMATERIALS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 359. RUSSIA BIOMATERIALS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 360. RUSSIA BIOMATERIALS MARKET SIZE, BY CERAMICS, 2017-2032 (USD MILLION)
TABLE 361. RUSSIA BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2017-2032 (USD MILLION)
TABLE 362. RUSSIA BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 363. RUSSIA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 364. RUSSIA BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 365. RUSSIA BIOMATERIALS MARKET SIZE, BY DENTAL, 2017-2032 (USD MILLION)
TABLE 366. RUSSIA BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 367. RUSSIA BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2017-2032 (USD MILLION)
TABLE 368. RUSSIA BIOMATERIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 369. BRAZIL BIOMATERIALS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 370. BRAZIL BIOMATERIALS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 371. BRAZIL BIOMATERIALS MARKET SIZE, BY CERAMICS, 2017-2032 (USD MILLION)
TABLE 372. BRAZIL BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2017-2032 (USD MILLION)
TABLE 373. BRAZIL BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 374. BRAZIL BIOMATERIALS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 375. BRAZIL BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 376. BRAZIL BIOMATERIALS MARKET SIZE, BY DENTAL, 2017-2032 (USD MILLION)
TABLE 377. BRAZIL BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 378. BRAZIL BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2017-2032 (USD MILLION)
TABLE 379. BRAZIL BIOMATERIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 380. CANADA BIOMATERIALS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 381. CANADA BIOMATERIALS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 382. CANADA BIOMATERIALS MARKET SIZE, BY CERAMICS, 2017-2032 (USD MILLION)
TABLE 383. CANADA BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2017-2032 (USD MILLION)
TABLE 384. CANADA BIOMATERIALS MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 385. CANADA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 386. CANADA BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 387. CANADA BIOMATERIALS MARKET SIZE, BY DENTAL, 2017-2032 (USD MILLION)
TABLE 388. CANADA BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2017-2032 (USD MILLION)
TABLE 389. CANADA BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2017-2032 (USD MILLION)
TABLE 390. CANADA BIOMATERIALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 391. ITALY BIOMATERIALS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 392. ITALY BIOMATERIALS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 393. ITALY BIOMATERIALS MARKET SIZE, BY CERAMICS, 2017-2032 (USD MILLION)
TABLE 394. ITA

Companies Mentioned

  • Aroa Biosurgery Limited
  • BASF SE
  • Berkeley Advanced Biomaterials Inc.
  • Bezwada Biomedical, LLC
  • Carpenter Technology Corporation
  • Celanese Corporation
  • CoorsTek, Inc.
  • Corbion N.V.
  • Covestro AG
  • Dentsply Sirona Inc.
  • DSM-Firmenich AG
  • Evonik Industries AG
  • Exactech, Inc.
  • Heraeus Holding GmbH
  • Integra LifeSciences Corporation
  • Invibio Limited
  • Modern Meadow, Inc.
  • MycoWorks, Inc.
  • Noble Biomaterials, Inc.
  • Stryker Corporation
  • TissueForm, Inc.
  • W. L. Gore & Associates, Inc.

Table Information

Report AttributeDetails
No. of Pages191
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 63.02 Billion
Forecasted Market Value ( USD ) by 2032 $ 131.3 Billion
Compound Annual Growth Rate12.9%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Topics

Related Reports

Biomedical Materials Market in the US 2026-2030 - Product Image

Biomedical Materials Market in the US 2026-2030

  • Report
  • 210 Pages
  • United States
From
Biomaterials - Global Strategic Business Report - Product Image

Biomaterials - Global Strategic Business Report

  • Report
  • 378 Pages
  • Global
From
Biomaterial Testing Equipment Market - Global Forecast 2026-2032 - Product Image

Biomaterial Testing Equipment Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Orthopedic Biomaterials Market - Global Forecast 2026-2032 - Product Image

Orthopedic Biomaterials Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Bioglass Fibers - Global Strategic Business Report - Product Image

Bioglass Fibers - Global Strategic Business Report

  • Report
  • 278 Pages
  • Global
From

About the Biomaterials Market

The Biomaterials market is a sector of the healthcare industry that focuses on the development and production of materials used in medical treatments and procedures. These materials are designed to interact with biological systems to improve patient outcomes. Examples of biomaterials include implants, prosthetics, tissue engineering scaffolds, and drug delivery systems. Biomaterials are used in a variety of medical applications, such as orthopedic surgery, cardiovascular surgery, and dental implants. They are also used in the development of medical devices, such as pacemakers, stents, and artificial organs. The biomaterials market is highly competitive, with many companies competing to develop and produce the most advanced materials. Some of the leading companies in the market include Johnson & Johnson, Zimmer Biomet, Stryker, and Medtronic. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.